Ontario at BIO 2025 | Source From Ontario

Ontario is taking life sciences to the next level, tackling some of the biggest health related challenges worldwide. The BIO International Convention 2025 is set to be the largest event for biotechnology and life sciences, bringing together over 20,000 global industry leaders, representing the most comprehensive ecosystem of industry and innovation.

Join us at booth #1035 to connect with globally recognized life sciences organizations at the forefront of research, innovation, and clinical trials. In this time of progress and revolutionary change in the way we heal, live, and care, Ontario’s delegation to BIO is leading the way. Meet with renowned innovators, ecosystem partners, research organizations and companies. Here’s how to connect:

Contact Patricia Cosgrove for information about the 22 Ontario Trade Mission companies participating in BIO’s Business Partnering.

Contact Charley Ford – based in Ontario’s Trade and Investment Office, New York City – about building international partnerships, events and networking opportunities.

Meet Your Next Life Sciences Partner among our proud showcase of nearly 200 Ontario companies and organizations at BIO 2025.

Participants

23 in total

20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
Since 2001, BioScript Solutions has supported patients with chronic illnesses and rare diseases by providing…
Custom Biologics provides regulatory compliant potency testing and assay services for all phases of…
Dalriada is a leading North American discovery company pioneering its novel Turn-Key™ model in small molecule…
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target HDAC6 to address…
ImmunoBiochem is an innovative biopharmaceutical company developing novel bioconjugate therapeutics, such …
Invest Ontario is a provincial agency dedicated to securing private sector strategic business and capital…
Raising capital is a key challenge for executives at early-stage therapeutics companies. Lumerate is launching…
mDETECT offers highly sensitive and cost-effective blood tests that can measure tumour behaviour irrespective of…
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small…
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP…
Paradox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating…
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
QReserve provides powerful enterprise-grade scheduling and resource management software to world-class…
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class…
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number…
Stiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and…
Sussex Research Laboratories Inc. (Ottawa, Canada) is recognized as a leader in the design and synthesis of…
SYNG Pharma is developing a new first-in-class diagnostic test and non-hormonal therapy for endometriosis. The…
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…
VeriLuce Therapeutics is an early-stage drug company developing novel small molecules targeting in dual…
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the…
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress…